Article: Blood pressure medication and acute kidney injury after intracerebral haemorrhage: an analysis of the ATACH-II trial

Background: Acute blood pressure (BP) reduction is standard of care after acute intracerebral haemorrhage (ICH). More acute BP reduction is associated with acute kidney injury (AKI). It is not known if the choice of antihypertensive medications affects the risk of AKI.

Methods: We analysed data from the ATACH-II clinical trial. AKI was defined by the Kidney Disease: Improving Global Outcomes criteria. We analysed antihypertensive medication from two sources. The first was a case report form that specified the use of labetalol, diltiazem, urapidil or other. We tested the hypothesis that the secondary medication was associated with AKI with χ test. Second, we tested the hypotheses the dosage of diltiazem was associated with AKI using Mann-Whitney U test.

Results: AKI occurred in 109 of 1000 patients (10.9%). A higher proportion of patients with AKI received diltiazem after nicardipine (12 (29%) vs 21 (12%), p=0.03). The 95%ile (90%-99% ile) of administered diltiazem was 18 (0-130) mg in patients with AKI vs 0 (0-30) mg in patients without AKI (p=0.002). There was no apparent confounding by indication for diltiazem use.

Conclusions: The use of diltiazem, and more diltiazem, was associated with AKI in patients with acute ICH.

Citing Articles

Phenotypes of Patients with Intracerebral Hemorrhage, Complications, and Outcomes.

Murphy J, Silva Pinheiro do Nascimento J, Houskamp E, Wang H, Hutch M, Liu Y Neurocrit Care. 2024; 42(1):39-47.

PMID: 39107659 DOI: 10.1007/s12028-024-02067-2.

References

1.

Li Q, Warren A, Qureshi A, Morotti A, Falcone G, Sheth K . Ultra-Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage. Ann Neurol. 2020; 88(2):388-395. PMC: 8697414. DOI: 10.1002/ana.25793. View

2.

Qureshi A, Palesch Y, Suarez J . Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. N Engl J Med. 2016; 375(23):e48. DOI: 10.1056/NEJMc1613117. View

3.

Greenberg S, Ziai W, Cordonnier C, Dowlatshahi D, Francis B, Goldstein J . 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022; 53(7):e282-e361. DOI: 10.1161/STR.0000000000000407. View

4.

Qureshi A, Huang W, Lobanova I, Hanley D, Hsu C, Malhotra K . Systolic Blood Pressure Reduction and Acute Kidney Injury in Intracerebral Hemorrhage. Stroke. 2020; 51(10):3030-3038. DOI: 10.1161/STROKEAHA.120.030272. View

5.

Brinjikji W, Demchuk A, Murad M, Rabinstein A, McDonald R, McDonald J . Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke. Stroke. 2017; 48(7):1862-1868. DOI: 10.1161/STROKEAHA.117.016771. View

6.

Darmon M, Bourmaud A, Reynaud M, Rouleau S, Meziani F, Boivin A . Performance of Doppler-based resistive index and semi-quantitative renal perfusion in predicting persistent AKI: results of a prospective multicenter study. Intensive Care Med. 2018; 44(11):1904-1913. DOI: 10.1007/s00134-018-5386-3. View

7.

Anderson C, Chalmers J, Stapf C . Blood-pressure lowering in acute intracerebral hemorrhage. N Engl J Med. 2013; 369(13):1274-5. DOI: 10.1056/NEJMc1309586. View

8.

Carcel C, Wang X, Sato S, Stapf C, Sandset E, Delcourt C . Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results. Stroke. 2016; 47(6):1651-3. DOI: 10.1161/STROKEAHA.116.013326. View

9.

. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet. 2019; 393(10175):1009-1020. PMC: 6497986. DOI: 10.1016/S0140-6736(19)30194-1. View

10.

Lameire N, Levin A, Kellum J, Cheung M, Jadoul M, Winkelmayer W . Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021; 100(3):516-526. DOI: 10.1016/j.kint.2021.06.028. View

Blood Pressure Medication and Acute Kidney Injury After Intracerebral Haemorrhage: an Analysis of the ATACH-II Trial